Global Prostate Cancer Diagnostics Market Analysis 2013-2018 and Forecast 2019-2024
March 2019
84
About the Report
About the Report
Snapshot
The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Prostate Cancer Diagnostics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tumor Biomarker Tests
Imaging
Biopsy
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
< 55
55-75
> 75
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Products
Table of Contents
Table of Contents
Table of Contents
1 Industry Overview
1.1 Prostate Cancer Diagnostics Industry
1.1.1 Overview
1.1.2 Development of Prostate Cancer Diagnostics
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Prostate Cancer Diagnostics Market by Type
3.1 By Type
3.1.1 Tumor Biomarker Tests
3.1.2 Imaging
3.1.3 Biopsy
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Prostate Cancer Diagnostics Genomic Health (Company Profile, Sales Data etc.)
4.2 Abbott (Company Profile, Sales Data etc.)
4.3 OPKO (Company Profile, Sales Data etc.)
4.4 Siemens Healthcare (Company Profile, Sales Data etc.)
4.5 DiaSorin (Company Profile, Sales Data etc.)
4.6 bioMeriux (Company Profile, Sales Data etc.)
4.7 Roche (Company Profile, Sales Data etc.)
4.8 MDx Health (Company Profile, Sales Data etc.)
4.9 Beckman Coulter (Company Profile, Sales Data etc.)
4.10 Myriad Genetics (Company Profile, Sales Data etc.)
4.11 Ambry Genetics (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in < 55
6.1.2 Demand in 55-75
6.1.3 Demand in > 75
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List of Figure
Figure Global Prostate Cancer Diagnostics Market Growth 2013-2018, by Type, in USD Million
Figure Global Prostate Cancer Diagnostics Market Growth 2013-2018, by Type, in Volume
Figure North America Prostate Cancer Diagnostics Market Concentration, in 2018
Figure Europe Prostate Cancer Diagnostics Market Market Concentration, in 2018
Figure Asia-Pacific Prostate Cancer Diagnostics MMarket Concentration, in 2018
Figure South America Prostate Cancer Diagnostics Market Concentration, in 2018
Figure Middle East & Africa Prostate Cancer Diagnostics Market Concentration, in 2018
Figure Prostate Cancer Diagnostics Demand in < 55, 2013-2018, in USD Million
Figure Prostate Cancer Diagnostics Demand in < 55, 2013-2018, in Volume
Figure Prostate Cancer Diagnostics Demand in 55-75, 2013-2018, in USD Million
Figure Prostate Cancer Diagnostics Demand in 55-75, 2013-2018, in Volume
Figure Prostate Cancer Diagnostics Demand in > 75, 2013-2018, in USD Million
Figure Prostate Cancer Diagnostics Demand in > 75, 2013-2018, in Volume
Figure North America Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure North America Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in Volume
Figure Europe Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Europe Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in Volume
Figure South America Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure South America Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
List of Table
Table Upstream Segment of Prostate Cancer Diagnostics
Table Application Segment of Prostate Cancer Diagnostics
Table Global Prostate Cancer Diagnostics Market 2013-2024, by Application, in USD Million
Table Major Company List of Tumor Biomarker Tests
Table Major Company List of Imaging
Table Major Company List of Biopsy
Table Major Company List of Others
Table Global Prostate Cancer Diagnostics Market 2013-2018, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market 2013-2018, by Type, in Volume
Table Global Prostate Cancer Diagnostics Market Forecast 2019-2024, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market Forecast 2019-2024, by Type, in Volume
Table Genomic Health Overview List
Table Prostate Cancer Diagnostics Business Operation of Genomic Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Prostate Cancer Diagnostics Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OPKO Overview List
Table Prostate Cancer Diagnostics Business Operation of OPKO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Siemens Healthcare Overview List
Table Prostate Cancer Diagnostics Business Operation of Siemens Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DiaSorin Overview List
Table Prostate Cancer Diagnostics Business Operation of DiaSorin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table bioMeriux Overview List
Table Prostate Cancer Diagnostics Business Operation of bioMeriux (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Prostate Cancer Diagnostics Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MDx Health Overview List
Table Prostate Cancer Diagnostics Business Operation of MDx Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beckman Coulter Overview List
Table Prostate Cancer Diagnostics Business Operation of Beckman Coulter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Myriad Genetics Overview List
Table Prostate Cancer Diagnostics Business Operation of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ambry Genetics Overview List
Table Prostate Cancer Diagnostics Business Operation of Ambry Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Prostate Cancer Diagnostics Sales Revenue 2013-2018, by Company, in USD Million
Table Global Prostate Cancer Diagnostics Sales Revenue Share, by Company, in USD Million
Table Global Prostate Cancer Diagnostics Sales Volume 2013-2018, by Company, in Volume
Table Global Prostate Cancer Diagnostics Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Prostate Cancer Diagnostics Demand Forecast 2019-2024, by Application, in USD Million
Table Prostate Cancer Diagnostics Demand Forecast 2019-2024, by Application, in Volume
Table Prostate Cancer Diagnostics Production 2013-2018, by Region, in USD Million
Table Prostate Cancer Diagnostics Production 2013-2018, by Region, in Volume
Table Global Prostate Cancer Diagnostics Market 2013-2018, by Region, in USD Million
Table Global Prostate Cancer Diagnostics Market Share 2013-2018, by Region, in USD Million
Table Global Prostate Cancer Diagnostics Market 2013-2018, by Region, in Volume
Table Global Prostate Cancer Diagnostics Market Share 2013-2018, by Region, in Volume
Table North America Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table North America Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in Volume
Table Europe Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Europe Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in Volume
Table South America Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table South America Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Prostate Cancer Diagnostics Market Size 2013-2018, by Country, in Volume
Table Prostate Cancer Diagnostics Market Forecast 2019-2024, by Region, in USD Million
Table Prostate Cancer Diagnostics Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.